Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Priming or flow checks also use insulin
Clinical studies demonstrate that semaglutide achieves glycemic control with HbA1c reductions of 1.5% to 1.8% at antidiabetic doses (Ozempic 0.5-1.0 mg, Rybelsus 7-14 mg) and produces weight loss ranging from 5-10% in type 2 diabetes and 12-15% with higher doses (Wegovy 2.4 mg) in patients with obesity
Typical Wegovy timeline: Weeks 1-4 (0.25mg): Starting dose hunger will decrease but may effects may wear off after 4-5 days post injection Weeks 5-8 (0.5mg): First increase hunger should feel more consistently lower, but effects may still wear off close to your next injection Weeks 9-12 (1.0mg): Second increase hunger lowering effect should be stronger at this stage, and the drug should have reached its steady state and have a more stable effect Weeks 13-16 (1.7mg): Third increase significantly lower hunger and food cravings without dips in hunger levels between injections Weeks 17+ (2.4mg): Maintenance dose stable hunger levels with low food cravings Based on clinical trial data, you can expect to lose up to 5% of your weight in the first month on Wegovy and up to 8% after two months
The extent of medication reduction depends on your starting point, how well you respond to semaglutide, and your baseline diabetes severity
US$ 24.06
US$ 22.85
US$ 21.52
US$ 27.82
